Back to results
US 2015/0105418 A1Published application
Substituted hydroxamic acids and uses thereof
AssigneeMillennium Pharmaceuticals, Inc.
InventorsChristopher Blackburn, Kenneth M. Gigstad, He Xu
Life of this patent
Estimating the term…
Abstract
This invention provides compounds of formula (I): wherein R1a, R1b, R1c, R1d, R2a, R2b, X1, X2, and G have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
Claims29
A compound of formula (I):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- one of X1 and X2 is CR1 and the other is N;
- or both X1 and X2 are N;
- one of R2a and R2b is R1, and the other is —C(O)—NH—OH;
- R1a is hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- R1b is hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- or R1a and R1b are taken together to form a 3 to 6 membered cycloaliphatic;
- R1c and R1d are:
- I) each occurrence of R1c is independently hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- and each occurrence of R1d is independently hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- or
- II) two occurrences of R1c are taken together to form ═O;
- and each occurrence of R1d is independently hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- or
- III) two occurrences of R1d are taken together to form ═O;
- and each occurrence of R1c is independently hydrogen, fluoro, C1-4 alkyl, or C1-4 fluoroalkyl;
- each occurrence of R1 is independently hydrogen, chloro, fluoro, —O—C1-4 alkyl, cyano, hydroxy, C1-4 alkyl, or C1-4 fluoroalkyl;
- G is —R3, —V1—R3, —V1-L1-R3, -L2-V1—R3, L2-V2—R3, —V1-L1-V2—R3, or -L1-R3;
- L1 is unsubstituted or substituted C1-3 alkylene chain;
- L2 is unsubstituted or substituted C2-3 alkylene chain;
- V1 is —C(O)—, —C(S)—, —C(O)—N(R4a)—, —C(O)—O—, —S(O)2—, or —SO2—N(R4a)—;
- V2 is —N(R4a)—, —N(R4a)—C(O)—, —N(R4a)—SO2—, —SO2—N(R4a)—, —SO2—, —C(O)—, —C(O)—O—, —O—C(O)—, —O—, —S—, —N(R4a)—C(O)—N(R4a)—, —N(R4a)—C(O)—O—, —O—C(O)—N(R4a)—, or —N(R4a)—SO2—N(R4a)—;
- R3 is unsubstituted or substituted C1-6 aliphatic, unsubstituted or substituted 3-10-membered cycloaliphatic, unsubstituted or substituted 4-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur, unsubstituted or substituted 6-10-membered aryl, or unsubstituted or substituted 5-10-membered heteroaryl having 1-5 heteroatoms independently selected from nitrogen, oxygen, and sulfur;
- and
- each occurrence of R4a is independently hydrogen, or unsubstituted or substituted C1-4 aliphatic.
23 more elements
Dependencies are inferred from the claim text.